Anne S Reiner, Esther M John, Jennifer D Brooks, Charles F Lynch, Leslie Bernstein, Lene Mellemkjær, Kathleen E Malone, Julia A Knight, Marinela Capanu, Sharon N Teraoka, Patrick Concannon, Xiaolin Liang, Jane C Figueiredo, Susan A Smith, Marilyn Stovall, Malcolm C Pike, Robert W Haile, Duncan C Thomas, Colin B Begg, Jonine L Bernstein. J Clin Oncol 2013
Times Cited: 77
Times Cited: 77
Times Cited
Times Co-cited
Similarity
Declining incidence of contralateral breast cancer in the United States from 1975 to 2006.
Hazel B Nichols, Amy Berrington de González, James V Lacey, Philip S Rosenberg, William F Anderson. J Clin Oncol 2011
Hazel B Nichols, Amy Berrington de González, James V Lacey, Philip S Rosenberg, William F Anderson. J Clin Oncol 2011
35
Risk of second primary cancer in the contralateral breast in women treated for early-stage breast cancer: a population-based study.
Xiang Gao, Susan G Fisher, Bahman Emami. Int J Radiat Oncol Biol Phys 2003
Xiang Gao, Susan G Fisher, Bahman Emami. Int J Radiat Oncol Biol Phys 2003
28
Perceptions, knowledge, and satisfaction with contralateral prophylactic mastectomy among young women with breast cancer: a cross-sectional survey.
Shoshana M Rosenberg, Michaela S Tracy, Meghan E Meyer, Karen Sepucha, Shari Gelber, Judi Hirshfield-Bartek, Susan Troyan, Monica Morrow, Lidia Schapira, Steven E Come,[...]. Ann Intern Med 2013
Shoshana M Rosenberg, Michaela S Tracy, Meghan E Meyer, Karen Sepucha, Shari Gelber, Judi Hirshfield-Bartek, Susan Troyan, Monica Morrow, Lidia Schapira, Steven E Come,[...]. Ann Intern Med 2013
28
Increasing use of contralateral prophylactic mastectomy for breast cancer patients: a trend toward more aggressive surgical treatment.
Todd M Tuttle, Elizabeth B Habermann, Erin H Grund, Todd J Morris, Beth A Virnig. J Clin Oncol 2007
Todd M Tuttle, Elizabeth B Habermann, Erin H Grund, Todd J Morris, Beth A Virnig. J Clin Oncol 2007
27
Population-based study of contralateral prophylactic mastectomy and survival outcomes of breast cancer patients.
Isabelle Bedrosian, Chung-Yuan Hu, George J Chang. J Natl Cancer Inst 2010
Isabelle Bedrosian, Chung-Yuan Hu, George J Chang. J Natl Cancer Inst 2010
25
Perceptions of contralateral breast cancer: an overestimation of risk.
Andrea Abbott, Natasha Rueth, Susan Pappas-Varco, Karen Kuntz, Elizabeth Kerr, Todd Tuttle. Ann Surg Oncol 2011
Andrea Abbott, Natasha Rueth, Susan Pappas-Varco, Karen Kuntz, Elizabeth Kerr, Todd Tuttle. Ann Surg Oncol 2011
25
Contralateral breast cancer risk in BRCA1 and BRCA2 mutation carriers.
Monika K Graeser, Christoph Engel, Kerstin Rhiem, Dorothea Gadzicki, Ulrich Bick, Karin Kast, Ursula G Froster, Bettina Schlehe, Astrid Bechtold, Norbert Arnold,[...]. J Clin Oncol 2009
Monika K Graeser, Christoph Engel, Kerstin Rhiem, Dorothea Gadzicki, Ulrich Bick, Karin Kast, Ursula G Froster, Bettina Schlehe, Astrid Bechtold, Norbert Arnold,[...]. J Clin Oncol 2009
22
Clinical management factors contribute to the decision for contralateral prophylactic mastectomy.
Tari A King, Rita Sakr, Sujata Patil, Inga Gurevich, Michelle Stempel, Michelle Sampson, Monica Morrow. J Clin Oncol 2011
Tari A King, Rita Sakr, Sujata Patil, Inga Gurevich, Michelle Stempel, Michelle Sampson, Monica Morrow. J Clin Oncol 2011
22
Trends in contralateral prophylactic mastectomy for unilateral cancer: a report from the National Cancer Data Base, 1998-2007.
Katharine Yao, Andrew K Stewart, David J Winchester, David P Winchester. Ann Surg Oncol 2010
Katharine Yao, Andrew K Stewart, David J Winchester, David P Winchester. Ann Surg Oncol 2010
22
20
Prophylactic mastectomy for the prevention of breast cancer.
Liz Lostumbo, Nora E Carbine, Judi Wallace. Cochrane Database Syst Rev 2010
Liz Lostumbo, Nora E Carbine, Judi Wallace. Cochrane Database Syst Rev 2010
20
Predictors of contralateral breast cancer in BRCA1 and BRCA2 mutation carriers.
K Metcalfe, S Gershman, H T Lynch, P Ghadirian, N Tung, C Kim-Sing, O I Olopade, S Domchek, J McLennan, A Eisen,[...]. Br J Cancer 2011
K Metcalfe, S Gershman, H T Lynch, P Ghadirian, N Tung, C Kim-Sing, O I Olopade, S Domchek, J McLennan, A Eisen,[...]. Br J Cancer 2011
19
Contralateral breast cancer in BRCA1 and BRCA2 mutation carriers.
Kelly Metcalfe, Henry T Lynch, Parviz Ghadirian, Nadine Tung, Ivo Olivotto, Ellen Warner, Olufunmilayo I Olopade, Andrea Eisen, Barbara Weber, Jane McLennan,[...]. J Clin Oncol 2004
Kelly Metcalfe, Henry T Lynch, Parviz Ghadirian, Nadine Tung, Ivo Olivotto, Ellen Warner, Olufunmilayo I Olopade, Andrea Eisen, Barbara Weber, Jane McLennan,[...]. J Clin Oncol 2004
19
Contralateral prophylactic mastectomy is associated with a survival advantage in high-risk women with a personal history of breast cancer.
Judy C Boughey, Tanya L Hoskin, Amy C Degnim, Thomas A Sellers, Joanne L Johnson, Melanie J Kasner, Lynn C Hartmann, Marlene H Frost. Ann Surg Oncol 2010
Judy C Boughey, Tanya L Hoskin, Amy C Degnim, Thomas A Sellers, Joanne L Johnson, Melanie J Kasner, Lynn C Hartmann, Marlene H Frost. Ann Surg Oncol 2010
19
Increasing rates of contralateral prophylactic mastectomy among patients with ductal carcinoma in situ.
Todd M Tuttle, Stephanie Jarosek, Elizabeth B Habermann, Amanda Arrington, Anasooya Abraham, Todd J Morris, Beth A Virnig. J Clin Oncol 2009
Todd M Tuttle, Stephanie Jarosek, Elizabeth B Habermann, Amanda Arrington, Anasooya Abraham, Todd J Morris, Beth A Virnig. J Clin Oncol 2009
19
Efficacy of prophylactic mastectomy in women with unilateral breast cancer: a cancer research network project.
Lisa J Herrinton, William E Barlow, Onchee Yu, Ann M Geiger, Joann G Elmore, Mary B Barton, Emily L Harris, Sharon Rolnick, Roy Pardee, Gail Husson,[...]. J Clin Oncol 2005
Lisa J Herrinton, William E Barlow, Onchee Yu, Ann M Geiger, Joann G Elmore, Mary B Barton, Emily L Harris, Sharon Rolnick, Roy Pardee, Gail Husson,[...]. J Clin Oncol 2005
19
The risk of contralateral breast cancer in patients from BRCA1/2 negative high risk families as compared to patients from BRCA1 or BRCA2 positive families: a retrospective cohort study.
Kerstin Rhiem, Christoph Engel, Monika Graeser, Silke Zachariae, Karin Kast, Marion Kiechle, Nina Ditsch, Wolfgang Janni, Christoph Mundhenke, Michael Golatta,[...]. Breast Cancer Res 2012
Kerstin Rhiem, Christoph Engel, Monika Graeser, Silke Zachariae, Karin Kast, Marion Kiechle, Nina Ditsch, Wolfgang Janni, Christoph Mundhenke, Michael Golatta,[...]. Breast Cancer Res 2012
21
Population-based study of the risk of second primary contralateral breast cancer associated with carrying a mutation in BRCA1 or BRCA2.
Kathleen E Malone, Colin B Begg, Robert W Haile, Ake Borg, Patrick Concannon, Lina Tellhed, Shanyan Xue, Sharon Teraoka, Leslie Bernstein, Marinela Capanu,[...]. J Clin Oncol 2010
Kathleen E Malone, Colin B Begg, Robert W Haile, Ake Borg, Patrick Concannon, Lina Tellhed, Shanyan Xue, Sharon Teraoka, Leslie Bernstein, Marinela Capanu,[...]. J Clin Oncol 2010
16
Contralateral prophylactic mastectomy: long-term consistency of satisfaction and adverse effects and the significance of informed decision-making, quality of life, and personality traits.
Marlene H Frost, Tanya L Hoskin, Lynn C Hartmann, Amy C Degnim, Joanne L Johnson, Judy C Boughey. Ann Surg Oncol 2011
Marlene H Frost, Tanya L Hoskin, Lynn C Hartmann, Amy C Degnim, Joanne L Johnson, Judy C Boughey. Ann Surg Oncol 2011
16
Patient and surgeon characteristics associated with increased use of contralateral prophylactic mastectomy in patients with breast cancer.
Amanda K Arrington, Stephanie L Jarosek, Beth A Virnig, Elizabeth B Habermann, Todd M Tuttle. Ann Surg Oncol 2009
Amanda K Arrington, Stephanie L Jarosek, Beth A Virnig, Elizabeth B Habermann, Todd M Tuttle. Ann Surg Oncol 2009
16
Epidemiology of contralateral breast cancer.
Y Chen, W Thompson, R Semenciw, Y Mao. Cancer Epidemiol Biomarkers Prev 1999
Y Chen, W Thompson, R Semenciw, Y Mao. Cancer Epidemiol Biomarkers Prev 1999
16
Relevance of breast cancer hormone receptors and other factors to the efficacy of adjuvant tamoxifen: patient-level meta-analysis of randomised trials.
C Davies, J Godwin, R Gray, M Clarke, D Cutter, S Darby, P McGale, H C Pan, C Taylor, Y C Wang,[...]. Lancet 2011
C Davies, J Godwin, R Gray, M Clarke, D Cutter, S Darby, P McGale, H C Pan, C Taylor, Y C Wang,[...]. Lancet 2011
15
Use of and mortality after bilateral mastectomy compared with other surgical treatments for breast cancer in California, 1998-2011.
Allison W Kurian, Daphne Y Lichtensztajn, Theresa H M Keegan, David O Nelson, Christina A Clarke, Scarlett L Gomez. JAMA 2014
Allison W Kurian, Daphne Y Lichtensztajn, Theresa H M Keegan, David O Nelson, Christina A Clarke, Scarlett L Gomez. JAMA 2014
15
Effect of anastrozole and tamoxifen as adjuvant treatment for early-stage breast cancer: 10-year analysis of the ATAC trial.
Jack Cuzick, Ivana Sestak, Michael Baum, Aman Buzdar, Anthony Howell, Mitch Dowsett, John F Forbes. Lancet Oncol 2010
Jack Cuzick, Ivana Sestak, Michael Baum, Aman Buzdar, Anthony Howell, Mitch Dowsett, John F Forbes. Lancet Oncol 2010
14
Second primary breast cancer occurrence according to hormone receptor status.
Allison W Kurian, Laura A McClure, Esther M John, Pamela L Horn-Ross, James M Ford, Christina A Clarke. J Natl Cancer Inst 2009
Allison W Kurian, Laura A McClure, Esther M John, Pamela L Horn-Ross, James M Ford, Christina A Clarke. J Natl Cancer Inst 2009
14
Factors affecting the decision of breast cancer patients to undergo contralateral prophylactic mastectomy.
Min Yi, Kelly K Hunt, Banu K Arun, Isabelle Bedrosian, Angelica Gutierrez Barrera, Kim-Anh Do, Henry M Kuerer, Gildy V Babiera, Elizabeth A Mittendorf, Kaylene Ready,[...]. Cancer Prev Res (Phila) 2010
Min Yi, Kelly K Hunt, Banu K Arun, Isabelle Bedrosian, Angelica Gutierrez Barrera, Kim-Anh Do, Henry M Kuerer, Gildy V Babiera, Elizabeth A Mittendorf, Kaylene Ready,[...]. Cancer Prev Res (Phila) 2010
14
Association between contralateral prophylactic mastectomy and breast cancer outcomes by hormone receptor status.
Abenaa M Brewster, Isabelle Bedrosian, Patricia A Parker, Wenli Dong, Susan K Peterson, Scott B Cantor, Melissa Crosby, Yu Shen. Cancer 2012
Abenaa M Brewster, Isabelle Bedrosian, Patricia A Parker, Wenli Dong, Susan K Peterson, Scott B Cantor, Melissa Crosby, Yu Shen. Cancer 2012
25
Review of risk factors for the development of contralateral breast cancer.
Ingrid M Lizarraga, Sonia L Sugg, Ronald J Weigel, Carol E H Scott-Conner. Am J Surg 2013
Ingrid M Lizarraga, Sonia L Sugg, Ronald J Weigel, Carol E H Scott-Conner. Am J Surg 2013
24
Growing Use of Contralateral Prophylactic Mastectomy Despite no Improvement in Long-term Survival for Invasive Breast Cancer.
Stephanie M Wong, Rachel A Freedman, Yasuaki Sagara, Fatih Aydogan, William T Barry, Mehra Golshan. Ann Surg 2017
Stephanie M Wong, Rachel A Freedman, Yasuaki Sagara, Fatih Aydogan, William T Barry, Mehra Golshan. Ann Surg 2017
14
Estrogen receptor, progesterone receptor, and HER2-neu expression in first primary breast cancers and risk of second primary contralateral breast cancer.
Babette Siebold Saltzman, Kathleen E Malone, Jean A McDougall, Janet R Daling, Christopher I Li. Breast Cancer Res Treat 2012
Babette Siebold Saltzman, Kathleen E Malone, Jean A McDougall, Janet R Daling, Christopher I Li. Breast Cancer Res Treat 2012
33
Risk reduction of contralateral breast cancer and survival after contralateral prophylactic mastectomy in BRCA1 or BRCA2 mutation carriers.
T C van Sprundel, M K Schmidt, M A Rookus, R Brohet, C J van Asperen, E J Th Rutgers, L J Van't Veer, R A E M Tollenaar. Br J Cancer 2005
T C van Sprundel, M K Schmidt, M A Rookus, R Brohet, C J van Asperen, E J Th Rutgers, L J Van't Veer, R A E M Tollenaar. Br J Cancer 2005
12
Twenty-year follow-up of a randomized trial comparing total mastectomy, lumpectomy, and lumpectomy plus irradiation for the treatment of invasive breast cancer.
Bernard Fisher, Stewart Anderson, John Bryant, Richard G Margolese, Melvin Deutsch, Edwin R Fisher, Jong-Hyeon Jeong, Norman Wolmark. N Engl J Med 2002
Bernard Fisher, Stewart Anderson, John Bryant, Richard G Margolese, Melvin Deutsch, Edwin R Fisher, Jong-Hyeon Jeong, Norman Wolmark. N Engl J Med 2002
12
Contralateral prophylactic mastectomy improves the outcome of selected patients undergoing mastectomy for breast cancer.
E A Peralta, J D Ellenhorn, L D Wagman, A Dagis, J S Andersen, D Z Chu. Am J Surg 2000
E A Peralta, J D Ellenhorn, L D Wagman, A Dagis, J S Andersen, D Z Chu. Am J Surg 2000
12
Contralateral mastectomy and survival after breast cancer in carriers of BRCA1 and BRCA2 mutations: retrospective analysis.
Kelly Metcalfe, Shelley Gershman, Parviz Ghadirian, Henry T Lynch, Carrie Snyder, Nadine Tung, Charmaine Kim-Sing, Andrea Eisen, William D Foulkes, Barry Rosen,[...]. BMJ 2014
Kelly Metcalfe, Shelley Gershman, Parviz Ghadirian, Henry T Lynch, Carrie Snyder, Nadine Tung, Charmaine Kim-Sing, Andrea Eisen, William D Foulkes, Barry Rosen,[...]. BMJ 2014
12
Comparison of patient characteristics and outcomes of contralateral prophylactic mastectomy and unilateral total mastectomy in breast cancer patients.
Alice Chung, Kelly Huynh, Camelia Lawrence, Myung-Shin Sim, Armando Giuliano. Ann Surg Oncol 2012
Alice Chung, Kelly Huynh, Camelia Lawrence, Myung-Shin Sim, Armando Giuliano. Ann Surg Oncol 2012
13
Satisfaction after contralateral prophylactic mastectomy: the significance of mastectomy type, reconstructive complications, and body appearance.
Marlene H Frost, Jeffrey M Slezak, Nho V Tran, Constance I Williams, Joanne L Johnson, John E Woods, Paul M Petty, John H Donohue, Clive S Grant, Jeff A Sloan,[...]. J Clin Oncol 2005
Marlene H Frost, Jeffrey M Slezak, Nho V Tran, Constance I Williams, Joanne L Johnson, John E Woods, Paul M Petty, John H Donohue, Clive S Grant, Jeff A Sloan,[...]. J Clin Oncol 2005
11
Increasing rates of contralateral prophylactic mastectomy - a trend made in USA?
U Güth, M E Myrick, C T Viehl, W P Weber, A M Lardi, S M Schmid. Eur J Surg Oncol 2012
U Güth, M E Myrick, C T Viehl, W P Weber, A M Lardi, S M Schmid. Eur J Surg Oncol 2012
15
Contralateral prophylactic mastectomy: what do we know and what do our patients know?
Seema A Khan. J Clin Oncol 2011
Seema A Khan. J Clin Oncol 2011
40
Issues of regret in women with contralateral prophylactic mastectomies.
L L Montgomery, K N Tran, M C Heelan, K J Van Zee, M J Massie, D K Payne, P I Borgen. Ann Surg Oncol 1999
L L Montgomery, K N Tran, M C Heelan, K J Van Zee, M J Massie, D K Payne, P I Borgen. Ann Surg Oncol 1999
10
The impact of adjuvant therapy on contralateral breast cancer risk and the prognostic significance of contralateral breast cancer: a population based study in the Netherlands.
Michael Schaapveld, Otto Visser, W J Louwman, Pax H B Willemse, Elisabeth G E de Vries, Winette T A van der Graaf, Renée Otter, Jan Willem W Coebergh, Flora E van Leeuwen. Breast Cancer Res Treat 2008
Michael Schaapveld, Otto Visser, W J Louwman, Pax H B Willemse, Elisabeth G E de Vries, Winette T A van der Graaf, Renée Otter, Jan Willem W Coebergh, Flora E van Leeuwen. Breast Cancer Res Treat 2008
10
Study design: evaluating gene-environment interactions in the etiology of breast cancer - the WECARE study.
Jonine L Bernstein, Bryan Langholz, Robert W Haile, Leslie Bernstein, Duncan C Thomas, Marilyn Stovall, Kathleen E Malone, Charles F Lynch, Jørgen H Olsen, Hoda Anton-Culver,[...]. Breast Cancer Res 2004
Jonine L Bernstein, Bryan Langholz, Robert W Haile, Leslie Bernstein, Duncan C Thomas, Marilyn Stovall, Kathleen E Malone, Charles F Lynch, Jørgen H Olsen, Hoda Anton-Culver,[...]. Breast Cancer Res 2004
10
Contralateral mastectomy improves survival in women with BRCA1/2-associated breast cancer.
D Gareth R Evans, Sarah L Ingham, Andrew Baildam, Gary L Ross, Fiona Lalloo, Iain Buchan, Anthony Howell. Breast Cancer Res Treat 2013
D Gareth R Evans, Sarah L Ingham, Andrew Baildam, Gary L Ross, Fiona Lalloo, Iain Buchan, Anthony Howell. Breast Cancer Res Treat 2013
10
Cancer risks for BRCA1 and BRCA2 mutation carriers: results from prospective analysis of EMBRACE.
Nasim Mavaddat, Susan Peock, Debra Frost, Steve Ellis, Radka Platte, Elena Fineberg, D Gareth Evans, Louise Izatt, Rosalind A Eeles, Julian Adlard,[...]. J Natl Cancer Inst 2013
Nasim Mavaddat, Susan Peock, Debra Frost, Steve Ellis, Radka Platte, Elena Fineberg, D Gareth Evans, Louise Izatt, Rosalind A Eeles, Julian Adlard,[...]. J Natl Cancer Inst 2013
10
Tamoxifen and risk of contralateral breast cancer for BRCA1 and BRCA2 mutation carriers.
Kelly-Anne Phillips, Roger L Milne, Matti A Rookus, Mary B Daly, Antonis C Antoniou, Susan Peock, Debra Frost, Douglas F Easton, Steve Ellis, Michael L Friedlander,[...]. J Clin Oncol 2013
Kelly-Anne Phillips, Roger L Milne, Matti A Rookus, Mary B Daly, Antonis C Antoniou, Susan Peock, Debra Frost, Douglas F Easton, Steve Ellis, Michael L Friedlander,[...]. J Clin Oncol 2013
10
Contralateral prophylactic mastectomy for breast cancer: addressing peace of mind.
Steven J Katz, Monica Morrow. JAMA 2013
Steven J Katz, Monica Morrow. JAMA 2013
12
Effect of systemic adjuvant treatment on risk for contralateral breast cancer in the Women's Environment, Cancer and Radiation Epidemiology Study.
Lisbeth Bertelsen, Leslie Bernstein, Jørgen H Olsen, Lene Mellemkjaer, Robert W Haile, Charles F Lynch, Kathleen E Malone, Hoda Anton-Culver, Jane Christensen, Bryan Langholz,[...]. J Natl Cancer Inst 2008
Lisbeth Bertelsen, Leslie Bernstein, Jørgen H Olsen, Lene Mellemkjaer, Robert W Haile, Charles F Lynch, Kathleen E Malone, Hoda Anton-Culver, Jane Christensen, Bryan Langholz,[...]. J Natl Cancer Inst 2008
12
Changing surgical trends in young patients with early stage breast cancer, 2003 to 2010: a report from the National Cancer Data Base.
Catherine E Pesce, Erik Liederbach, Tomasz Czechura, David J Winchester, Katharine Yao. J Am Coll Surg 2014
Catherine E Pesce, Erik Liederbach, Tomasz Czechura, David J Winchester, Katharine Yao. J Am Coll Surg 2014
10
Operative risks associated with contralateral prophylactic mastectomy: a single institution experience.
Megan E Miller, Tomasz Czechura, Brigid Martz, Mary E Hall, Catherine Pesce, Nora Jaskowiak, David J Winchester, Katharine Yao. Ann Surg Oncol 2013
Megan E Miller, Tomasz Czechura, Brigid Martz, Mary E Hall, Catherine Pesce, Nora Jaskowiak, David J Winchester, Katharine Yao. Ann Surg Oncol 2013
10
Survival outcomes after contralateral prophylactic mastectomy: a decision analysis.
Pamela R Portschy, Karen M Kuntz, Todd M Tuttle. J Natl Cancer Inst 2014
Pamela R Portschy, Karen M Kuntz, Todd M Tuttle. J Natl Cancer Inst 2014
12
Contralateral prophylactic mastectomy after unilateral breast cancer: a systematic review and meta-analysis.
Oluwadamilola Motunaryo Fayanju, Carolyn R T Stoll, Susan Fowler, Graham A Colditz, Julie A Margenthaler. Ann Surg 2014
Oluwadamilola Motunaryo Fayanju, Carolyn R T Stoll, Susan Fowler, Graham A Colditz, Julie A Margenthaler. Ann Surg 2014
10
Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.